Search
for
Sort by
Research 30 of 1000+
- Hair eruption initiates and commensal skin microbiota aggravate adverse events of anti-EGFR therapy
- Association of melanoma and nonmelanoma skin cancer with antihypertensive drugs: A report from the Research on Adverse Drug events And Reports project
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Dermatological adverse events with taxane chemotherapy
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Dupilumab‐associated cutaneous adverse events among adult patients with atopic dermatitis: A retrospective study
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Dermatologic adverse events in EGFR-TKIs: A real-world analysis.
- 176 Hair eruption initiates adverse events of EGFR-targeted cancer therapy
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Target-Adverse Events and Fear of Cancer Progression, Anxiety, and Depression in Patients with Advanced Non-Small Cell Lung Cancer
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Adverse events of non-ablative fractional laser photothermolysis: a retrospective study of 856 treatments in 362 patients
- A rare adverse event following laser hair reduction
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Profile analysis of adverse events after boron neutron capture therapy for head and neck cancer: a sub-analysis of the JHN002 study
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- 329 Mechanisms of Cutaneous Adverse Events during Targeted Cancer Therapy
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- Clinical development and management of adverse events associated with FGFR inhibitors
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C
- Pharmacotherapy of plexiform neurofibromas in patients with neurofibromatosis type 1. Possible adverse events and their management
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Dermatologic Adverse Events from Cancer Treatments